LeonaBio (LONA) Operating Leases (2020 - 2026)

LeonaBio (LONA) has 7 years of Operating Leases data on file, last reported at $213000.0 in Q1 2026.

• Operating Leases for Q1 2026 came in at $213000.0, down 69.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $213000.0 (down 69.18% YoY), and the FY2025 annual result was $338000.0, down 57.91% from the prior year.
• Operating Leases slipped to $213000.0 in Q1 2026 per LONA's latest filing, from $338000.0 in the prior quarter.
• Over five years, Operating Leases peaked at $1.8 million in Q2 2022 and troughed at $213000.0 in Q1 2026.
• A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2022 and 2026: Operating Leases decreased 1.52% in 2022, then tumbled 69.18% in 2026.
• A 5-year view of Operating Leases shows it stood at $1.6 million in 2022, then declined by 23.22% to $1.2 million in 2023, then sank by 34.02% to $803000.0 in 2024, then slumped by 57.91% to $338000.0 in 2025, then slumped by 36.98% to $213000.0 in 2026.
• Business Quant data shows LONA's Operating Leases at $213000.0 in Q1 2026, $338000.0 in Q4 2025, and $460000.0 in Q3 2025.